Drugs / Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011
Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01161264 | Jul 2010 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01161264 ↗ |
| Modality | Vaccine | “trivalent inactivated influenza vaccine” NCT01161264 ↗ |
| Route | Intramuscular | “administered into the deltoid muscle” NCT01161264 ↗ |